Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus

PLoS Pathogens

Volumn 7, Issue 12, 2011, Pages

  Safronetz, David ^a   Zivcec, Marko ^a,b   LaCasse, Rachel ^a   Feldmann, Friederike ^a   Rosenke, Rebecca ^a   Long, Dan ^a   Haddock, Elaine ^a   Brining, Douglas ^a   Gardner, Donald ^a   Feldmann, Heinz ^a,b   Ebihara, Hideki ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIGEN;

ANDES VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HANTAVIRUS PULMONARY SYNDROME; HISTOPATHOLOGY; INNATE IMMUNITY; INOCULATION; NONHUMAN; NOSE INFECTION; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOPHYSIOLOGY; SYRIAN HAMSTER; TH1 CELL; TH2 CELL; VIRUS; VIRUS DETECTION; ANIMAL; DISEASE MODEL; FEMALE; HAMSTER; HANTAVIRUS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; ISOLATION AND PURIFICATION; LUNG; PATHOGENICITY; PATHOLOGY; REGULATORY T LYMPHOCYTE; VIROLOGY;

ANDES VIRUS; ANIMALIA; CRICETINAE; HANTAVIRUS; MESOCRICETUS AURATUS;

ADMINISTRATION, INTRANASAL; ANIMALS; CRICETINAE; DISEASE MODELS, ANIMAL; FEMALE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HOST-PATHOGEN INTERACTIONS; LUNG; MESOCRICETUS; T-LYMPHOCYTES, REGULATORY;

EID: 84855265604     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002426     Document Type: Article

References (54)

1. Schmaljohn C, Nichol ST, (2007) Bunyaviridae. In: Knipe DM, Howley PA, editors. Field's virology 5th ed Philadelphia Lippincott-Williams & Wilkins pp. 1742-1789.
2. Nichol ST, Elliott RM, Goldbach R, Plyusnin A, Schmaljohn CS, et al. (2005) Bunyaviridae. In: Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, editors. Virus Taxonomy, VIIIth Report of the International Committee on Taxonomy of Viruses London Elsevier Academic Press pp. 695-716.
3. Jonsson CB, Figueiredo LTM, Vapalahti O, (2010) A global perspective on hantavirus ecology, epidemiology and disease. Clin Microbiol Rev 23: 412-441.
4. Khan AS, Young JC, (2001) Hantavirus pulmonary syndrome: at the cross roads. Curr Opin Infect Dis 14: 205-209.
5. CDC (2010) Hantavirus pulmonary syndrome (Hantavirus disease) (HPS) 2010 case definition. Available: http://www.cdc.gov/ncphi/disss/nndss/casedef/hantaviruscurrent.htm. Accessed 2 July 2010.
6. Enria DA, Briggiler AM, Pini N, Levis S, (2001) Clinical manifestations of New World hantaviruses. Curr Top Microbiol Immunol 256: 117-134.
7. Geimonen E, Neff S, Raymond T, Kocer SS, Gavrilovskaya, et al. (2002) Pathogenic and non-pathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci USA 99: 13837-13842.
8. Levine JR, Prescott J, Brown KS, Best SM, Ebihara H, et al. (2010) Antagonism of type I interferon responses by New World hantaviruses. J Virol 84: 11790-11801.
9. Alff PJ, Gavrilovskaya IN, Gorbunova E, Endriss K, Chong Y, et al. (2006) The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80: 9676-9686.
10. Spiropoulou CF, Albarino CG, Ksiazek TG, Rollin PE, (2007) Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signalling. J Virol 81: 2769-2776.
11. Borges AA, Campos GM, Moreli ML, Souza RLM, Saggioro FP, et al. (2008) Role of Th1 and Th2 cytokines on pathogenesis and prognosis of hantavirus cardiopulmonary syndrome. Microbe Infect 10: 1150-1157.
12. Mori M, Rothman AL, Kurane I, Montoya JM, Nolte KB, et al. (1999) High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179: 295-302.
13. Kilpatrick ED, Terajima M, Koster FT, Catalina MD, Cruz J, et al. (2004) Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172: 3297-3304.
14. Groen J, Gerding M, Koeman JP, Roholl PJ, van Amerongen G, et al. (1995) A macaque model for hantavirus infection. J Infect Dis 172: 38-44.
15. Klingstrom J, Plyusnin A, Vaheri A, Lundkvist A, (2002) Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol 76: 444-449.
16. Sironen T, Klingstrom J, Vaheri A, Andersson LC, Lundkvist A, et al. (2008) Pathology of Puumala hantavirus infection in macaques. PLoS One 3: e3035.
17. Hooper JW, Larsen T, Custer DM, Schmaljohn CS, (2001) A lethal disease model for hantavirus pulmonary syndrome. Virology 289: 6-14.
18. Campen MJ, Milazzo ML, Fulhorst CF, Obot Akata CJ, Koster F, (2006) Characterization of shock in a hamster model of hantavirus infection. Virology 356: 45-49.
19. Wahl-Jensen V, Chapman J, Asher L, Fisher R, Zimmerman M, et al. (2007) Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. J Virol 81: 7449-7462.
20. Milazzo ML, Eyzaguirre EJ, Molina CP, Fulhorst C, (2002) Maporal viral infection in the Syrian golden hamsters: a model of hantavirus pulmonary syndrome. J Infect Dis 186: 1390-1395.
21. Eyzaguirre EJ, Milazzo ML, Koster FT, Fulhorts C, (2008) Choclo virus infection in the Syrian golden hamster. Am J Trop Med Hyg 78: 669-674.
22. Safronetz D, Hegde NR, Ebihara H, Denton M, Kobinger GP, et al. (2009) Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with Andes virus. J Virol 83: 7285-7295.
23. Zivcec M, Safronetz D, Haddock E, Feldmann H, Ebihara H, (2011) Validation of assays to monitor immune responses in Syrian hamsters (Mesocricetus auratus). J Immunol Method 368: 24-35.
24. Gowen BB, Julander JG, London NR, Wong M-H, Larson D, et al. (2010) Assessing changes in vacular permeability in a hamster model of viral hemorrhagic fever. Virology J 7: 240.
25. Zaki SR, Greer PW, Coffield LM, Goldsmith CS, Nolte KB, et al. (1995) Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146: 552-579.
26. Toro J, Vega JD, Khan AS, Mills JN, Padula P, et al. (1998) An outbreak of hantavirus pulmonary syndrome, Chile, 1997. Emerg Infect Dis 4: 687-694.
27. Rowe RK, Pekosz A, (2006) Bidirectional secreation and nonciliated cell tropism following andes virus infection of primary airway epithelial cell cultures. J Virol 80: 1087-1097.
28. Padula PJ, Edelstein A, Miquel SD, Lopez NM, Rossi CM, et al. (1998) Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus. Virol 241: 323-330.
29. Martinez VP, Bellomo C, San Juan J, Pinna D, Forlenza R, et al. (2005) Person-to-person transmission of Andes virus. Emerg Infect Dis 11: 1848-1853.
30. Castillo C, Naranjo J, Seoulveda A, Ossa G, Levy H, (2001) Hantavirus pulmonary syndrome due to Andes virus in Temuco, Chile: clinical experience with 16 adults. Chest 120: 548-554.
31. Shrivastava-Ranjan P, Rollin P, Spiropoulou CF, (2010) Andes virus disrupts the endothelial cell barrier by induction of vascular endothelial growth factor and downregulation of VE-Cadherin. J Virol 84: 11227-11234.
32. Rouse BT, Horohov DW, (1986) Immunosuppression in viral infections. Rev Infect Dis 8: 850-873.
33. Tortorella D, Gewurz BE, Furman MH, Schist DJ, Ploegh HL, (2000) Viral subversion of the immune system. Annu Rev Immunol 18: 861-926.
34. Stoltz M, Ahlm C, Lundkvist A, Klingstrom J, (2007) Lambda interferon (IFN-lambda) in serum is decreased in hantavirus-infected patients, and in vitro-established infection is insensitive to treatment with all IFNs and inhibits IFN-gamma-induced nitric oxide production. J Virol 81: 8685-8691.
35. Robertson SJ, Hasenkrug KJ, (2006) The role of virus-induced regulatory T cells in immunopathology. Springer Semin Immunopathol 28: 51-62.
36. Rouse BT, Suvas S, (2004) Regulatory cells and infectious agents: detentes cordiale and contraire. J Immunol 173: 2211-2215.
37. Schountz T, Prescott J, Cogswell AC, Oko L, Mirowsky-Garcia K, et al. (2007) Regulatory T cell-like responses in deer mice persistently infected with Sin Nombre virus. Proc Natl Acad Sci USA 104: 15496-15501.
38. Easterbrook JD, Zink MC, Klein SL, (2007) Regulatory T cells enhance persistence of the zoonotic pathogen Seoul virus in its reservoir host. Proc Natl Acad Sci USA 104: 15502-15507.
39. Easterbrook JD, Klein SL, (2008) Immunological mechanisms mediating hantavirus persistence in rodent reservoirs. PLoS Pathog 4: e1000172.
40. Zhu LY, Chi LJ, Wang X, Zhou H, (2009) Reduced circulating CD4+CD25+ cell populations in haemorrhagic fever with renal syndrome. Clin Exp Immunol 156: 88-96.
41. Saggioro FP, Rossi MA, Duarte MIS, Martin CCS, Alves VAF, et al. (2007) Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 195: 1541-1549.
42. Khaiboullina SF, Netski DM, Krumpe P, St Joer SC, (2000) Effects of tumor necrosis factor alpha on sin nombre virus infection in vitro. J Virol 74: 11966-11971.
43. Mackow ER, Gavrilovskaya IN, (2009) Hantavirus regulation of endothelial cell functions. Thromb Haemost 102: 1030-1041.
44. Janssen SP, Gayan-Ramirez G, Van den Bergh A, Herijgers P, Maes K, et al. (2005) Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats. Circulation 111: 996-1005.
45. Hedayat M, Mahmoudi MJ, Rose NR, Rezaei N, (2010) Proinflammatory cytokines in heart failure: double-edged swords. Heart Fail Rev 15: 543-562.
46. Afanayeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, et al. (2001) Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 104: 3145-3151.
47. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector cells develop via a lineage distinct from T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132.
48. Tesmer LA, Lundy SK, Sarkar S, Fox DA, (2008) Th17 cells in human disease. Immunol Rev 223: 87-113.
49. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, et al. (2008) Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 127: 89-97.
50. Tang TT, Ding YJ, Liao YH, Yu X, Xiao H, et al. (2010) Defective circulating CD4+CD25+Foxp3+CD127low regulatory T-cells in patients with chronic heart failure. Cell Physiol Biochem 25: 451-458.
51. Hammerbeck CD, Hooper JW, (2011) T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. J Virol 85: 9929-9944.
52. Terajima M, Ennis FA, (2011) T cells and pathogenesis of hantavirus cardiopulmonary syndrome and hemorrhagic fever with renal syndrome. Viruses 3: 1059-1073.
53. Sundstrom JB, McMullan LK, Spiropoulou CF, Hooper WC, Ansari AA, et al. (2001) Hanyavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 75: 6070-6085.
54. Meissner JD, Rowe JE, Borucki MK, Joer SC St, (2002) Complete nucleotide sequence of a Chilean hantavirus. Virus Res 89: 131-143.